Protective role of interleukin-12 in viral myocarditis

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 9, 1997, Pages 2327-2334

  Shioi, Tetsuo ^a   Matsumori, Akira ^a   Nishio, Ryosuke ^a   Ono, Koh ^a   Kakio, Tadashi ^a   Sasayama, Shigetake ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cytokine; Heart failure; Interleukin 12; Myocarditis; Virus

Indexed keywords

CYTOKINE ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 12;

ANIMAL EXPERIMENT; ARTICLE; ENCEPHALOMYOCARDITIS VIRUS; EXPERIMENTAL INFECTION; GENE EXPRESSION; HEART MUSCLE INJURY; HEART PROTECTION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS MYOCARDITIS; VIRUS REPLICATION;

ANIMALIA; ENCEPHALOMYOCARDITIS VIRUS; MURINAE;

EID: 0031239333     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0445     Document Type: Article

References (37)

1. ARAI KI, LEE F, MIYAJIMA A, MIYATAKE S, ARAI N, YOKOTA T, 1990. Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem 59: 783-836.
2. BALKWILL FR, BURKE F, 1989. The cytokine network. Immunol Today 10: 299-304.
3. BI Z, QUANDT P, KOMATSU T, BARNA M, REISS CS, 1995. IL-20 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system. J Immunol 155: 5684-5689.
4. BOST KL, CLEMENTS JD, 1995. In vivo induction of interleukin-12 mRNA expression after oral immunization with Salmonella dublin or the B subunit of Escherichia coli heat-labile enterotoxin. Infect Immun 63: 1076-1083.
5. CAR BD, ENG VM, SCHNYDER B, LEHIR M, SHAKHOV AN, WOERLY G, HUANG S, AGUET M, ANDERSON TD, RYFFIELL B, 1995. Role of interferon-gamma in interleukin 12-induced pathology in mice [see comments]. Am J Pathol 147: 1693-1707.
6. CHOMCZYNSKI P, SACCHI N, 1987. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem 162: 156-159.
7. COHEN J, 1995. IL-12 deaths: explanation and a puzzle [news]. Science 270: 908.
8. GODENY EK, GAUNTT CJ, 1986. Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis. J Immunol 137: 1695-1702.
9. GODENY EK, GAUNTT CJ, 1987. Murine natural killer cells limit coxsackievirus B3 replication. J Immunol 139: 913-918.
10. GRAY PW, GOEDDEL DV, 1983. Cloning and expression of murine immune interferon cDNA. Proc Natl Acad Sci USA 80: 5842-5846.
11. HEIM A, CANU A, KIRSCHNER P, SIMON T, MALL G, HOFSCHNEIDER PH, KANDOLF R, 1992. Synergistic interaction of interferon-beta and interferon-gamma in coxsackievirus B3-infected carrier cultures of human myocardial fibroblasts. J Infect Dis 166: 958-965.
12. HEINZEL FP, SCHOENHAUT DS, RERKO RM, ROSSER LE, GATELY MK, 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 177: 1505-1509.
13. HEINZEL FP, RERKO RM, AHMED F, PEARLMAN E, 1995. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J Immunol 155: 730-739.
14. HENDRZAK JA, BRUNDA MJ, 1995. Interleukin-12. Biologic activity, therapeutic utility, and role in disease. Lab Invest 72: 619-637.
15. KANANGAT S, THOMAS J, GANGAPPA S, BABU JS, ROUSE BT, 1996. Herpes simplex virus type 1-mediated upregulation of IL-12 (p40) mRNA expression. Implications in immunopathogenesis and protection. J Immunol 156: 1110-1116.
16. KOBAYASHI M, FITZ L, RYAN M, HEWICK RM, CLARK SC, CHAN S, LOUDON R, SHERMAN F, PERUSSIA B, TRINCHIERI G, 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170: 827-845.
17. LANE JR, NEUMANN DA, LAFOND WALKER A, HERSKOWITZ A, ROSE NR, 1993. Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis. J Immunol 151: 1682-1690.
18. MA Y, SEILER KP, TAI KF, YANG L, WOODS M, WEIS JJ, 1994. Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway. Infect Immune 62: 3663-3671.
19. MATSUI S, MATSUMORI A, MATOBA Y, UCHIDA A, SASAYAMA S, 1994. Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production. J Clin Invest 94: 1212-1217.
20. MATSUMORI A, YAMADA T, SUZUKI H, MATOBA Y, SASAYAMA S, 1994. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 72: 561-566.
21. MOORE KW, VIERA P, FIORENTINO DF, L TM, KHAN TA, MOSMANN TR, 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248: 1230-1234.
22. MORRIS SC, MADDEN KB, ADAMOVICZ JJ, GAUSE WC, HUBBARD BR, GATELY MK, FINKELMAN FD, 1994. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J Immunol 152: 1047-1056.
23. ORANGE JS, WOLF SF, BIRON CA, 1994. Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol 152: 1253-1264.
24. OZMEN L, GRIBAUDO G, FOUNTOULAKIS M, GENTZ R, LANDOLFO S, GAROTTA G, 1993. Mouse soluble IFN gamma receptor as IFN gamma inhibitor. Distribution, antigenicity, and activity after injection in mice. J Immunol 150: 2698-2705.
25. OZMEN L, AGUET M, TRINCHIERI G, GAROTTA G, 1995. The in vivo antiviral activity of interleukin-12 is mediated by gamma interferon. J Virol 69: 8147-8150.
26. SCHOENHAUT DS, CHUA AO, WOLITZKY AG, QUINN PM, DWYER CM, MCCOMAS W, FAMILLETTI PC, GATELY MK, GUBLER U, 1992. Cloning and expression of murine IL-12. J Immunol 148: 3433-3440.
27. SCOTT P, KAUFMANN SH, 1991. The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today 12: 346-348.
28. SHIOI T, MATSUMORI A, SASAYAMA S, 1996. Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation 94: 2930-2937.
29. SIELING PA, WANG XH, GATELY MK, OLIVEROS LJ, MCHUGH T, BARNES PF, WOLF SF, GOLKAR L, YAMAMURA M, YOGI Y, et al., 1994. IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J Immunol 153: 3639-3647.
30. SMITH SC, ALLEN PM, 1992. Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. Circ Res 70: 856-863.
31. STREET NE, MOSMANN TR, 1991. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. Faseb J 5: 171-177.
32. SYPEK JP, CHUNG CL, MAYOR SE, SUBRAMANYAM JM, GOLDMAN SJ, SIEBURTH DS, WOLF SF, SCHAUB RG, 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 177: 1797-1802.
33. TOKUNAGA K, TANIGUCHI H, YODA K, SHIMIZU M, SAKIYAMA S, 1986. Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA. Nucleic Acids Res 14: 2829.
34. TRIPP CS, GATELY MK, HAKIMI J, LING P, UNANUE ER, 1994. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma. J Immunol 152: 1883-1887.
35. WANG ZE, ZHENG S, CORRY DB, DALTON DK, SEDER RA, REINER SL, LOCKSLEY RM, 1994. Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc Natl Acad Sci USA 91: 12932-12936.
36. WHITE LL, SMITH RA, 1990. D variant of encephalomyocarditis virus (EMCV-D)-induced diabetes following natural killer cell depletion in diabetes-resistant male C57BL/6J mice. Viral Immunol 3: 67-76.
37. YAMADA T, MATSUMORI A, SASAYAMA S, 1994. Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation 89: 846-851.